A comparative analysis of AD cases versus high-pathology control or NDAN subjects revealed no significant differences in levels of NFTs, rather showing that increased levels of phosphorylated tau in the synaptic compartment were associated with dementia (Perez-Nievas et al., 2013). The gene discussed is MAPT; the disease is Alzheimer disease.